Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CWK
CWK logo

CWK Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Cushman & Wakefield Ltd (CWK) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
12.890
1 Day change
0.55%
52 Week Range
17.400
Analysis Updated At
2026/05/22
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

CWK is not a good buy right now for a Beginner with a long-term preference and $50,000-$100,000 to invest. The stock has a weak technical setup, no proprietary buy signal, and analyst sentiment has been mixed to weaker with recent price target cuts. While there are some positive business catalysts, the current evidence does not support an immediate buy for a patient or impatient investor; hold is the clearest call.

Technical Analysis

The chart structure is bearish overall. MACD histogram is negative at -0.159, showing downside momentum remains in place, though it is contracting. RSI_6 at 38.319 is below the midpoint and reflects weak momentum without being deeply oversold. Moving averages are bearish with SMA_200 > SMA_20 > SMA_5, which confirms a downtrend. Price at 13.07 is sitting just above pivot 13.144 and above support S1 at 12.273, with resistance at 14.015 and 14.553. The recent pattern-based forecast suggests a short-term rebound probability, but the broader trend still does not show a clean long-term entry.

Options Data

Bullish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio

Options sentiment is bullish on balance from open interest, with a low put-call ratio of 0.27 suggesting more call positioning than puts. However, the daily option volume put-call ratio of 4.0 is put-heavy, showing near-term hedging or bearish trading activity. Implied volatility at 49.88 is elevated versus historical volatility 37.3, and option activity is far above average today versus the 30-day norm, but the mixed volume signal means options are not confirming a strong buy.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
8
Buy
1

Positive Catalysts

  • Recent news is constructive: Cushman & Wakefield arranged $74.1 million in financing for a San Jose mixed-use conversion project, which supports advisory and development-related revenue potential. The company also won a five-year valuation mandate from SEGRO covering a large UK portfolio, which is a good recurring-services catalyst. The stock trend model also points to a possible near-term bounce, with estimated upside over the next day, week, and month.

Neutral/Negative Catalysts

  • Analyst sentiment has weakened recently, with Barclays cutting its target to $15 from $19 and citing weaker investor sentiment in commercial real estate services. Goldman Sachs also lowered its target to $19.50 from $22.25, even while keeping Buy. Technically, the stock remains in a bearish trend and has not reclaimed key resistance levels. Hedge fund and insider trading trends are neutral, offering no strong accumulation signal. There is no recent congress trading data.

Financial Performance

No financial snapshot was available, so latest-quarter revenue or earnings growth cannot be assessed. Because of the missing financial data, there is no evidence here to support a strong fundamental buy case for a beginner long-term investor.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Wall Street is mixed but trending more cautious. Goldman Sachs remains bullish with a Buy rating but lowered its price target, while Barclays downgraded its target and kept Equal Weight, explicitly pointing to weaker investor sentiment. Overall, the pros view is that CWK has business activity and some upside potential, but the cons view is stronger right now because target cuts signal reduced confidence and the stock is not showing a strong technical turnaround.

Wall Street analysts forecast CWK stock price to rise
5 Analyst Rating
Wall Street analysts forecast CWK stock price to rise
4 Buy
1 Hold
0 Sell
Strong Buy
Current: 12.820
sliders
Low
18
Averages
18.75
High
19
Current: 12.820
sliders
Low
18
Averages
18.75
High
19
Barclays
Brendan Lynch
Equal Weight
downgrade
$19 -> $15
AI Analysis
2026-03-13
Reason
Barclays
Brendan Lynch
Price Target
$19 -> $15
AI Analysis
2026-03-13
downgrade
Equal Weight
Reason
Barclays analyst Brendan Lynch lowered the firm's price target on Cushman & Wakefield to $15 from $19 and keeps an Equal Weight rating on the shares. The firm cites weaker investor sentiment on the commercial real estate services group for the target cut.
Goldman Sachs
Buy
downgrade
2026-02-27
Reason
Goldman Sachs
Price Target
2026-02-27
downgrade
Buy
Reason
Goldman Sachs lowered the firm's price target on Cushman & Wakefield to $19.50 from $22.25 and keeps a Buy rating on the shares.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CWK
Unlock Now

People Also Watch